SC
Suriyan Chandrasekar
About Suriyan Chandrasekar
Data last updated:
Suriyan Chandrasekar is a Director at Bageo Pharmaceuticals Private Limited (since 2019). The company operates in Business Services. Bageo Pharmaceuticals Private Limited reported revenue of ₹1.24 Cr (FY 2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 24 Jan 2019 | 2019 | ₹1.24 Cr (FY 2022) | Active |
Board colleagues of Suriyan Chandrasekar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Balachandar Chinnasamy | 08341822 | Bageo Pharmaceuticals Private Limited | Director |
| Chandran Sathishkumar | 09409872 | Bageo Pharmaceuticals Private Limited | Director |
| Mohammed Abdul Salam Mohamed Abdul Rahim | 08341834 | Bageo Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Suriyan Chandrasekar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Suriyan Chandrasekar
Suriyan Chandrasekar currently holds 1 directorship: Bageo Pharmaceuticals Private Limited (Director, since 24 Jan 2019, revenue ₹1.24 Cr (FY 2022)).
Suriyan Chandrasekar was first appointed on 24 Jan 2019 as Director at Bageo Pharmaceuticals Private Limited.
The current boards of Suriyan Chandrasekar's companies include Balachandar Chinnasamy (Bageo Pharmaceuticals Private Limited), Chandran Sathishkumar (Bageo Pharmaceuticals Private Limited), Mohammed Abdul Salam Mohamed Abdul Rahim (Bageo Pharmaceuticals Private Limited).